No AccessJournal of UrologyAdult Urology1 Dec 2013

Can Magnetic Resonance-Ultrasound Fusion Biopsy Improve Cancer Detection in Enlarged Prostates?

    View All Author Information


    Patients with an enlarged prostate and suspicion of prostate cancer pose a diagnostic dilemma. The prostate cancer detection rate of systematic 12-core transrectal ultrasound guided biopsy is between 30% and 40%. For prostates greater than 40 cc this decreases to 30% or less. Magnetic resonance-ultrasound fusion biopsy has shown superior prostate cancer detection rates. We defined the detection rate of magnetic resonance-ultrasound fusion biopsy in men with an enlarged prostate gland.

    Materials and Methods:

    We retrospectively analyzed the records of patients who underwent multiparametric prostate magnetic resonance imaging followed by magnetic resonance-ultrasound fusion biopsy at our institution. Whole prostate volumes were calculated using magnetic resonance imaging reconstructions. Detection rates were analyzed with respect to age, prostate specific antigen and whole prostate volumes. Multivariable logistic regression was used to assess these parameters as independent predictors of prostate cancer detection.


    We analyzed 649 patients with a mean ± SD age of 61.8 ± 7.9 years and a median prostate specific antigen of 6.65 ng/ml (IQR 4.35–11.0). Mean whole prostate volume was 58.7 ± 34.3 cc. The overall detection rate of the magnetic resonance-ultrasound fusion platform was 55%. For prostates less than 40 cc the detection rate was 71.1% compared to 57.5%, 46.9%, 46.9% 33.3%, 36.4% and 30.4% for glands 40 to 54.9, 55 to 69.9, 70 to 84.9, 85 to 99.9, 100 to 114.9 and 115 cc or greater, respectively (p <0.0001). Multivariable logistic regression showed a significant inverse association of magnetic resonance imaging volume with prostate cancer detection, controlling for age and prostate specific antigen.


    Transrectal ultrasound guided and fusion biopsy cancer detection rates decreased with increasing prostate volume. However, magnetic resonance-ultrasound fusion biopsy had a higher prostate cancer detection rate compared to that of transrectal ultrasound guided biopsy in the literature. Magnetic resonance-ultrasound fusion biopsy represents a promising solution for patients with suspicion of prostate cancer and an enlarged prostate.


    • 1 American Cancer Society: Prostate Cancer. Available at United States of America 2013. Accessed February 27, 2012. Google Scholar
    • 2 : Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol1989; 142. Google Scholar
    • 3 : EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Uro2011; 59: 61. Google Scholar
    • 4 : The relationship of prostate gland volume to extended needle biopsy on prostate cancer detection. J Urol2003; 169: 130. LinkGoogle Scholar
    • 5 : Outcome of sextant biopsy according to gland volume. Urology1997; 49: 55. Google Scholar
    • 6 : Optimization of prostate cancer diagnosis by increasing the number of core biopsies based on gland volume. Int J Clin Exp Pathol2012; 5: 892. Google Scholar
    • 7 : Is it effective to perform two more prostate biopsies according to prostate-specific antigen level and prostate volume in detecting prostate cancer? Prospective study of 10-core and 12-core prostate biopsy. Urology2012; 9: 491. Google Scholar
    • 8 : Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate. Urology2003; 61: 1181. Google Scholar
    • 9 : Multiparametric MRI for prostate cancer localization in correlation to whole-mount histopathology. J Magn Reson Imaging2013; 37: 1392. Google Scholar
    • 10 : Clinical application of a 3D ultrasound-guided prostate biopsy system. Urol Oncol2011; 29: 334. Google Scholar
    • 11 : Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy. BJU Int2008; 101: 841. Google Scholar
    • 12 : Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol2011; 59: 477. Google Scholar
    • 13 : Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol2011; 186: 1281. LinkGoogle Scholar
    • 14 : Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol2011; 186: 1818. LinkGoogle Scholar
    • 15 : Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer. BJU Int2012; 110: E783. Google Scholar
    • 16 : Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients. BJU Int2012; 110: 1642. Google Scholar
    • 17 : Making the most out of six systematic sextant biopsies. Urology1995; 45: 2. Google Scholar
    • 18 : Update on prostate biopsy technique. Curr Opin Urol2004; 14: 157. Google Scholar
    • 19 : Use of extended systematic sampling in patients with a prior negative prostate needle biopsy. J Urol2002; 167: 2457. LinkGoogle Scholar
    • 20 : Office based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population. J Urol2011; 186: 850. LinkGoogle Scholar
    • 21 : Systematic transperineal ultrasound-guided template biopsy of the prostate: three-year experience. Urology2005; 65: 735. Google Scholar
    • 22 : Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era. J Natl Cancer Inst2007; 99: 1395. Google Scholar
    • 23 : Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol2006; 175: 1605. LinkGoogle Scholar
    • 24 : Origin and evolution of benign prostatic enlargement. Invest Urol1978; 15: 340. Google Scholar
    • 25 : The zonal anatomy of the prostate. Prostate1981; 2: 35. Google Scholar
    • 26 : MRI-ultrasound fusion for guidance of targeted prostate biopsy. Curr Opin Urol2013; 23: 43. Google Scholar
    • 27 : A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion. J Urol2011; 186: 2214. LinkGoogle Scholar
    • 28 Sonn GA, Chang E, Natarajan S et al: Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol, Epub ahead of print March 17, 2013. Google Scholar
    • 29 : The clinical management of patients with a small volume of prostatic cancer on biopsy: what are the risks of progression? A systematic review and meta-analysis. Cancer2008; 112: 971. Google Scholar
    • 30 : Image guidance in the focal treatment of prostate cancer. Curr Opin Urol2012; 22: 328. Google Scholar